InvestorsHub Logo
Followers 0
Posts 20
Boards Moderated 0
Alias Born 10/11/2014

Re: None

Sunday, 10/12/2014 2:40:42 PM

Sunday, October 12, 2014 2:40:42 PM

Post# of 12450
Hi Gary, NO NO NO its not three different substances. All the company states that they have film technology patent. Thats why im confused. Hope to get some clarity in it during the week. Reckitt Benckiser cooperate with MonoSolRx on the Suboxone. Biodelivery sciences will launch their product BUNAVAIL (buprenorphine and naloxone) now during Q4.

Bunavail, Suboxone are both same active substace which is: buprenorphine and naloxone, so is Intelgenx product. All three are same substances. In addition we have a Swedish company where I live named Orexo. They have a sublingual tablet named Zubsolv which also contain the same substance.

Orexo made a privat placement recently of 346 mil swedish kronor appr 47 mil us dollars to the expansion of Zubsolv in the USA.

Orexo is why im investing in Intelgenx. I bought Orexo shares couple of years ago at approx 3,5 us dollars and sold at 5 us dollars because I got insecure. I knew I liked their business idea and that their business will be great but still I sold due to insecurity. Now I see the same thing in Intelgenx that I saw and feelt with Orexo. Orexo is now at 15$ and was at 23-24$ earlier this year.


Just take a look at Biodelivery sciences stock. In two years it has gone approx 1500%. Under 1$ now 15$ and was 20$. I think Intelgenx will have the same trip.

Another thing. Intelgenx is long ahead with the Migrane medicine in comparision to http://www.monosolrx.com/content/pipeline/overview.htm
They are also interested in the same film. I guess that we will be seeing some fusions/buyouts between this 3-4 players.

There was a interview with Zerbes at bloomberg recently. During the interview he was asked if Intelgenx would be bought (min 5:20)

you clearly see his facial expresion that he has been offered deals and doesnt seem to need it. Cashburn is low. I think he knows what his doing. You clearly see that his not in it for the money. His old and wants to do good/legacy. Money will come for Intelgenx. Do what you like and be the best and money will come. Thats what I believe.

//

Michael
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News